
NVE Corporation (NVEC) is rated a long-term Buy due to its proprietary spintronics technology, expanding medical-device market presence, and robust profitability. NVEC's ultraminiature magnetic sensors target implantable medical devices, leveraging strong relationships with manufacturers like Abbott Laboratories and recent manufacturing expansions. FY2026 net profit margin reached 58%, with Q1 FY2027 revenue and net income up 81% and 79% respectively, demonstrating accelerating growth momentum.










